Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infectionChansavath Phetsouphanh, Gail Matthews|Nature Immunology|2022Cited by 987
Linkage and retention in <scp>HCV</scp> care for <scp>HIV</scp>‐infected populations: early data from the <scp>DAA</scp> eraRachel Sacks‐Davis, Margaret Hellard, Maria Prins et al.|Journal of the International AIDS Society|2018Cited by 53
A Randomized Trial of Nafamostat for Covid-19Susan C. Morpeth, Nigel Raymond, Balasubramanian Venkatesh et al.|NEJM Evidence|2023Cited by 14